Shenzhen Glory Medical Co.,Ltd. (SHE:002551)
China · Delayed Price · Currency is CNY 3.380
-0.030 (-0.88%)
Oct 8, 2026, 3:04 PM CST
Shenzhen Glory Medical Revenue
Shenzhen Glory Medical had revenue of 308.33M CNY in the quarter ending June 30, 2026, with 24.18% growth. This brings the company's revenue in the last twelve months to 1.11B, down -17.09% year-over-year. In the year 2025, Shenzhen Glory Medical had annual revenue of 1.08B, down -25.61%. That makes Shenzhen Glory Medical the 18,807th largest company in the world by revenue and 3,429th in China.
Revenue (ttm)
1.11B
Revenue Growth
-17.09%
P/S Ratio
2.56
Revenue / Employee
843.40K
Employees
1,322
Market Cap
2.85B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.08B | -370.90M | -25.61% |
| Dec 31, 2024 | 1.45B | 255.32M | 21.40% |
| Dec 31, 2023 | 1.19B | -82.82M | -6.49% |
| Jan 1, 2023 | 1.28B | -514.59M | -28.74% |
| Jan 1, 2022 | 1.79B | -477.00M | -21.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Jointown Pharmaceutical Group | 167.56B |
| C.Q. Pharmaceutical Holding | 81.39B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 77.91B |
| China National Accord Medicines Corporation | 72.89B |
| China National Medicines Corporation | 53.56B |
| China Meheco Group | 35.24B |
| Guangxi LiuYao Group | 21.15B |
| Liaoning Cheng Da | 9.21B |